BB Biotech AG (XSWX:BION) Net Income (Continuing Operations) : CHF-206.61 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. BB Biotech AG's Net Income (Continuing Operations) for the three months ended in Dec. 2023 was CHF109.12 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-206.61 Mil.

BB Biotech AG Net Income (Continuing Operations) Historical Data

The historical data trend for BB Biotech AG's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Net Income (Continuing Operations) Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

677.43

691.17

-404.81

-357.81

-206.61

BB Biotech AG Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-35.16	-253.86	-13.48	-48.39	109.12

BB Biotech AG Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-206.61 Mil.

BB Biotech AG (XSWX:BION) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

BB Biotech AG Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (XSWX:BION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

Executives

Prof. Dr. Mads Krogsgaard Thomsen

Supervisory Board

BB Biotech AG (XSWX:BION) Headlines

No Headlines